Translational Research Grants

The National Psoriasis Foundation (NPF) offers Translational Research Grants aimed at advancing the treatment and understanding of psoriasis and psoriatic arthritis. With over $30 million invested, these grants support research that translates scientific discoveries into clinical applications. Each project can receive up to $100,000 annually over a two-year period, fostering innovative solutions for patients. Applicants must possess an M.D., Ph.D., or equivalent degree and be eligible to act as Principal Investigators.

Each year, the National Psoriasis Foundation (NPF) awards grants and fellowships that fund work focused on the treatment, prevention, and cure of psoriasis, psoriatic arthritis (PsA), and comorbidities. NPF has invested over $30 million in grants and fellowships focused on psoriatic disease and related comorbidities.
As a primary goal in the current strategic plan, leading transformational research in psoriatic disease, NPF chooses research projects not only for their potential to yield information that may help treat psoriatic disease, but also to answer basic questions about the underlying disease mechanisms, comorbidities, and public health. Applications undergo a rigorous scientific peer review by a panel of experts.
Translational Research Grants fund research initiatives that focus on the rapid translation of basic scientific discoveries into clinical applications with a clear benefit for patients with psoriatic disease.
Budget and Project Period
Applicants may request up to $100,000 (direct cost only) per year. The total project period for the application submitted is two years beginning on August 1st.

Eligibility

Applicants must hold an M.D., Ph.D., or equivalent academic degree and be eligible to apply as a Principal Investigator by their institution.